Precision medicine in KCNJ11 permanent neonatal diabetes

類似資料

• Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations
  著者:: Letourneau, Lisa R., 等
  出版事項: (2019)
• Hypoglycemia in Sulfonylurea-Treated KCNJ11-Neonatal Diabetes: Mild-Moderate Symptomatic Episodes Occur Infrequently but None Involving Unconsciousness or Seizures
  著者:: Lanning, Monica S, 等
  出版事項: (2017)
• Early Intensive Insulin Use May Preserve β-Cell Function in Neonatal Diabetes Due to Mutations in the Proinsulin Gene
  著者:: Letourneau, Lisa R., 等
  出版事項: (2017)
• Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes
  著者:: Thurber, Brian W., 等
  出版事項: (2015)
• ADHD, Learning Difficulties and Sleep Disturbances Associated with KCNJ11-Related Neonatal Diabetes
  著者:: Landmeier, Karen A, 等
  出版事項: (2016)